NCT06678126View on ClinicalTrials.gov

Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients with Intermediate or High Risk Localized Prostate Cancer (ARP)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

June 30, 2033

Study Completion Date

January 31, 2035

Conditions
Prostate Cancer
Interventions
RADIATION

Prostate and Pelvic Nodes Radiotherapy

60 Gy prostate and 44 Gy pelvic nodes with 20 fractions

Trial Locations (1)

V5Z4E6

BC Cancer Vancouver, Vancouver

All Listed Sponsors
lead

Scott Tyldesley

OTHER